Edition:
United Kingdom

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

4.64USD
15 Dec 2017
Change (% chg)

$0.06 (+1.31%)
Prev Close
$4.58
Open
$4.59
Day's High
$4.77
Day's Low
$4.47
Volume
3,387,997
Avg. Vol
415,345
52-wk High
$8.37
52-wk Low
$4.33

Select another date:

Thu, Dec 14 2017

BRIEF-Biovectra And Keryx Biopharmaceuticals Enter Agreement For Ferric Citrate Production Expansion

* BIOVECTRA AND KERYX BIOPHARMACEUTICALS ENTER AGREEMENT FOR FERRIC CITRATE PRODUCTION EXPANSION

BRIEF-Keryx Biopharmaceuticals Q3 loss per share $0.20

* Keryx Biopharmaceuticals announces third quarter 2017 financial results

BRIEF-KERYX BIOPHARMACEUTICALS SAYS MICHAEL ROGERS APPOINTED CHAIRMAN OF BOARD

* KERYX BIOPHARMACEUTICALS ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

BRIEF-Keryx Biopharmaceuticals Inc - co and Patheon Inc entered into a product agreement - SEC filing​

* Keryx Biopharmaceuticals Inc - co and Patheon Inc entered into a product agreement - SEC filing​

BRIEF-Keryx Biopharmaceuticals Q2 loss per share $0.77

* Keryx Biopharmaceuticals announces second quarter 2017 financial results and increased 2017 u.s. Product sales guidance

Select another date: